Humira
® (
adalimumab) is a prescription medication approved to treat several inflammatory conditions that affect the joints, spine, and
digestive system.
It is made by Abbott Pharmaceuticals.
Specific uses of the drug include reducing the signs and symptoms of the following conditions:
Humira is part of a class of medicines known as tumor necrosis factor inhibitors, or TNF inhibitors for short.
As the name implies, the drug blocks the activity of tumor necrosis factor-alpha (TNF-alpha). TNF-alpha is a naturally occurring chemical in the body that is involved in inflammation and other immune system functions.
People with rheumatoid arthritis,
juvenile arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, or Crohn's disease often have higher levels of TNF. These high levels of TNF-alpha can cause inflammation and lead to problems. By blocking TNF-alpha, Humira helps to relieve the symptoms of these conditions and, in some cases, prevents future damage from occurring. Humira does not cure these conditions.